Robert Blum, President & CEO, Director at Cytokinetics, holds 465.39K shares in Cytokinetics (Ticker: CYTK), holds 96.50K shares in Gamida Cell (Ticker: GMDAQ).

See the Hottest Stocks Based on Insider Trading >

Robert Blum
Cytokinetics (CYTK)
President & CEO, Director

Ranked #96,150 out of 98,564 Corporate Insiders

Profitable Transactions

0 out of 11 Profitable Transactions

Average Return

-87.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

CYTK

<0.01%

GMDAQ

A breakdown of Robert Blum's holdings

See the Top Stocks by Insiders

Insider Roles

Cytokinetics
(CYTK)

President & CEO, Director

Gamida Cell
(GMDAQ)

Director

Roles that Robert Blum holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Cytokinetics
(CYTK)

Rating:Informative Sell

Date:May 18, 2020 - May 18, 2021

Return:-7.80%

The most profitable trade made by Robert Blum

See the Latest Stocks Traded by Insiders

Robert Blum's Trading History

CYTK

Cytokinetics

Mar 18, 2024

President & CEO, Director

Uninformative Buy

―

$30.52M

GMDAQ

Gamida Cell

Feb 10, 2023

Director

Uninformative Buy

―

$1.45K

List of latest transactions for each holding click on a transaction to see Robert Blum's performance on stock

See All Insider Trading from Today

Robert Blum insider profile FAQ

What is the percentage of profitable transactions made by Robert Blum?

The percentage of profitable transactions made by Robert Blum is 0%.

What is the average return per transaction made by Robert Blum?

The average return per transaction made by Robert Blum is -87.80%.

What stocks does Robert Blum hold?

Robert Blum holds: CYTK, GMDAQ stocks.

What was Robert Blum’s latest transaction?

Robert Blum latest transaction was an Uninformative Buy of ―.

What was Robert Blum's most profitable transaction?

Robert Blum’s most profitable transaction was an Informative Sell of CYTK stock on May 18, 2020. The return on the trade was -7.80%.

What is Robert Blum's role in Cytokinetics?

Robert Blum's role in Cytokinetics is President & CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Robert Blum Insider Profile

Robert Blum Cytokinetics (CYTK)President & CEO, Director